Coordinate expression of group II phospholipase A2 and the acute-phase proteins haptoglobin (HP) and α1-anti-chymotrypsin (ACH) by HepG2 cells

Clinical and Experimental Immunology

Volumn 108, Issue 1, 1997, Pages 175-180

  Vadas, P ^a,c   Grouix, B ^a   Stefanski, E ^a   Wloch, M ^a   Pruzanski, W ^a   Schroeder, J ^b   Gauldie, J ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Acute phase proteins; Cytokines; Haptoglobin; HepG2; 1 anti chymotrypsin

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTICHYMOTRYPSIN; CYTOKINE; DEXAMETHASONE; HAPTOGLOBIN; PHOSPHOLIPASE A2;

ARTICLE; DOWN REGULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL;

EID: 0030942052     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-990.x     Document Type: Article

References (33)

1. Richards CD, Brown TJ, Shoyab M, Baumann H, Gauldie J. Recombinant oncostatin M stimulates the production of acute phase proteins in Hep G2 cells and rat primary hepatocytes in vitro. J Immunol 1992; 148:1731-6.
2. Richards C, Gauldie J, Baumann H. Cytokine control of acute phase protein expression. Eur Cytokine Network 1991; 2:89-98.
3. Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular hospholipase A2 expression and inflammation: the relationship with associated disease states. J Lipid Mediators 1993; 8:1-30.
4. Glaser KB, Mobilio D, Chang JY, Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacolog Sci 1993; 14:92-98.
5. Vadas P, Pruzanski W. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. Circ Shock 1993; 39:160-7.
6. Vadas P, Stefanski E, Grouix B, Schouten BD, Pruzanski W. Inhibition of human group II phospholipase A2 by C-reactive protein in vitro. J Lipid Mediators & Cell Signalling 1995; 11:187-200.
7. Crowl RM, Stoller TJ, Conroy RR, Stoner CR. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 1991; 266:2647-51.
8. Smith GM, Ward RL, McGuigan L, Rajkovic IA, Scott KF. Measurement of human phospholipase A2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 1992; 31:175-8.
9. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Nat Sci Acad USA 1987; 84:7251-5.
10. Chomczynski P, Sacci N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Ann Biochem 1987; 162:156-9.
11. Sambrook T, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd edn, Vol. I. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989.
12. Pruzanski W, Vadas P. Phospholipase A2 - a mediator between proximal and distal effectors of inflammation. Immunol Today 1999; 12:143-6.
13. Matsuda Y, Ogawa M, Sakamoto K et al. Development of a radioimmunoassay for human group II phospholipase A2 and demonstration of a postoperative elevation. Enzyme 1991; 45:200-8.
14. Ogawa M, Arakawa H, Yamashita S, Sakamoto K, Ikei S. Postoperative elevations of serum interleukin 6 and group II phospholipase A2: group II phospholipase A2 in serum is an acute phase reactant. Res Communication Chem Pathol Pharmacol 1992; 75:109-15.
15. Uhl W, Beger HG, Hoffman G et al. A multicentre study of phospholipase A2 in patients in intensive care units. J Am Coll Surg 1995; 180:323-31.
16. Yin T, Taga T, Tsang ML, Yasukawa K, Kishimoto T, Yang YC. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transaction. J Immunol 1993; 151:2555-61.
17. Brown TJ, Rowe JM, Liu JW, Shoyab M. Regulation of IL-6 expression by oncostatin M. J Immunol 1991; 147:2175-80.
18. Fourcin M, Chevalier S, Lebrun JJ, Kelly P, Pouplard A, Wijdenes J, Gascan H. Involvement of gp130/interleukin-6 receptor transducing component in interleukin-11 receptor. Eur J Immunol 1994; 24:277-80.
19. Barton BE, Jackson JV, Lee F, Wagner J. Oncostatin M stimulates proliferation in B9 hybridoma cells: potential role of oncostatin M in plasmacytoma development. Cytokine 1994; 6:147-53.
20. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Molec Biol Med 1990; 7:147-59.
21. Nesbitt JE, Fuentes NL, Fuller GM. Ciliary neurotrophic factor regulates fibrinogen gene expression in hepatocytes by binding to the interleukin-6 receptor. Biochem Biophys Res Commun 1993; 190:544-50.
22. Oka S, Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem 1991; 266:9956-60.
23. Arita H, Nakano T, Ohara O, Teraoka H. Activation of group II phospholipase A2 gene via two distinct mechanisms in rat vascular smooth muscle cells. Adv Prosta Thrombox Leukotriene Res 1991; 21A:277-80.
24. Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL. Cytokine-induced gene expression of a neutrophil chemotactic factor/ IL-8 in human hepatocytes. J Immunol 1990; 144:2609-13.
25. Bauer J, Lengyel G, Bauer TM, Aos G, Gerok W. Regulation of interleukin-6 receptor expression in human monocytes and hepatocytes. FEBS Letters 1989; 249:27-30.
26. Schooltink H, Schmitz-van de Leur H, Heinrich PC, Rose-John S. Upregulation of the interleukin-6-signal transducing protein (gp130) by interleukin-6 and dexamethasone in HepG2 cells. FEBS Letters 1992; 297:263-5.
27. Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 1993; 260:1808-10.
28. Davis S, Aldrich TH, Stahl N, Pan L, Taga T, Kishimoto T, Ip NY, Yancopoulos GD. LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor. Science 1991; 260: 1805-8.
29. Olivier JJ, Fan Q, Salvat C, Ziari M, Kong L, Mangeney M, Bereziat G. Positive and negative hepatic regulation of the human type II phospholipase A2 gene. Biochem 1994; 33:7134-45.
30. Pfeilschifter J, Leighton J, Pignat W, Marki F, Vosberk K. Cyclic AMP mimics, but does not mediate, interleukin-1 and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat mesangial cells. Biochem J 1991; 273:199-204.
31. Grove RI, Mazzucco CE, Radka SF, Shoyab M, Kiener PA. Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. J Biol Chem 1991; 266:18194-9.
32. 2 mRNA and activity levels in interleukin I beta and forskolin-stimulated mesangial cells. Biochem J 1996; 315:435-41.
33. 2 by cytokines and its prevention by dexamethasone. Adv Exp Med Biol 1992; 318:1-10.